ULTIMO, Simona
 Distribuzione geografica
Continente #
NA - Nord America 1.026
EU - Europa 395
AS - Asia 218
SA - Sud America 13
OC - Oceania 5
AF - Africa 4
Totale 1.661
Nazione #
US - Stati Uniti d'America 1.021
PL - Polonia 192
CN - Cina 81
IT - Italia 72
SG - Singapore 55
DE - Germania 29
UA - Ucraina 27
ID - Indonesia 25
SE - Svezia 25
TR - Turchia 24
GB - Regno Unito 21
VN - Vietnam 19
FI - Finlandia 11
BE - Belgio 9
BR - Brasile 9
AU - Australia 5
CA - Canada 4
JP - Giappone 3
TW - Taiwan 3
EG - Egitto 2
IE - Irlanda 2
RO - Romania 2
SI - Slovenia 2
AR - Argentina 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IQ - Iraq 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
NG - Nigeria 1
NP - Nepal 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
VE - Venezuela 1
Totale 1.661
Città #
Warsaw 192
Fairfield 161
Woodbridge 113
Houston 92
Ann Arbor 83
Ashburn 79
Cambridge 70
Seattle 60
Chandler 59
Wilmington 52
Santa Clara 44
Jacksonville 38
Singapore 38
Jakarta 25
Izmir 22
Ferrara 21
Beijing 18
Dong Ket 17
Nanjing 15
Princeton 12
Shanghai 11
Boardman 10
Los Angeles 9
London 7
Falkenstein 6
Hebei 6
Helsinki 6
Nanchang 6
San Diego 6
Ghent 5
Shenyang 5
Atlanta 4
Brussels 4
Cagliari 4
Milan 4
Albuquerque 3
Changsha 3
Dearborn 3
Frankfurt am Main 3
Taipei 3
Tianjin 3
Aversa 2
Bologna 2
Casnate Con Bernate 2
Des Moines 2
Farra di Soligo 2
Focsani 2
Hangzhou 2
Hanoi 2
Mainz 2
Melbourne 2
Munich 2
New York 2
Parma 2
Pragersko 2
Tappahannock 2
Trieste 2
Wuhan 2
Adelaide 1
Auburn Hills 1
Baghdad 1
Bangkok 1
Braintree 1
Cary 1
Chicago 1
Chongqing 1
Dublin 1
Ecatepec 1
Falls Church 1
Fuzhou 1
Gangnam-gu 1
Giza 1
Greenwich 1
Itambé 1
Jinan 1
Kunming 1
Lanzhou 1
Liberty 1
Manchester 1
Manta 1
Meknes 1
Monte Grande 1
Montreal 1
Nagoya 1
Norwalk 1
Orange 1
Pato Branco 1
Phoenix 1
Pune 1
Redmond 1
Reutlingen 1
Salto 1
San Jose 1
San Mateo 1
Santo André 1
Serra 1
São Paulo 1
Taciba 1
Villamagna 1
Xian 1
Totale 1.398
Nome #
PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines 201
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 170
Impact of physical exercise in cancer survivors during and after antineoplastic treatments 159
Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise 157
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 156
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model 155
Synergistic effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway or NUP214-ABL1 fusion protein in human Acute Lymphoblastic Leukemia 152
Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia 151
Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments 136
Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases 116
Roles and clinical implications of microRNAs in acute lymphoblastic leukemia 115
Inhibition of the PI3K/Akt/mTOR signaling pathway as a therapeutic target for Acute Lymphoblastic Leukemia 64
Totale 1.732
Categoria #
all - tutte 7.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020181 0 0 0 0 0 38 31 31 34 15 14 18
2020/2021499 12 17 19 20 102 62 58 51 27 84 15 32
2021/2022105 9 5 1 1 11 12 3 2 6 19 16 20
2022/2023141 13 6 13 18 17 29 7 10 17 1 5 5
2023/202482 7 9 1 3 1 4 4 10 2 4 5 32
2024/2025185 14 16 40 20 57 38 0 0 0 0 0 0
Totale 1.732